Soligenix Extends Patent Protection for Filovirus Vaccine Platform to UK and South Africa Industry News April 25, 2024 …
Antiviral for Sudan Ebolavirus; Ebola Pathogenicity in Pigs; Repurposing SARS-CoV-2 Drugs for Marburg Pathogens April 3, 2024 …
Primmune Therapeutics Awarded DTRA Funding for Lassa Fever Antiviral Medical Countermeasures March 20, 2024 …
Phase 2 Clinical Trial for Marburg Vaccine Starts in Uganda Medical Countermeasures October 19, 2023 …
NIAID Study Shows Low-Dose Marburg Vaccine Effective in Macaques Medical Countermeasures August 25, 2023 …
Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding Industry News January 12, 2023 …
Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines Contracts + Grants October 21, 2021 …
The First Human Case of Marburg Virus in West Africa Highlights Importance of Quickly Detecting Spillover Events Biosurveillance August 30, 2021 …
Soligenix Announces Successful Demonstration of Heat Stabilization for Filovirus Vaccine Platform Medical Countermeasures March 3, 2020 …
Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans February 10, 2020 …
U.S. Supporting Ecological Surveillance for Special Pathogens in Sierra Leone Biosecurity April 28, 2019 …
Fundamental Research to Counter Biological, Chemical, and Nuclear Weapons Biosecurity September 21, 2018 …
Inhibiting PP2A-B56 to Suppress Ebola Virus Transcription and Infection Featured News January 22, 2018 …
BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures CBRNE November 16, 2017 …
NIAID Backs VesiculoVax Vaccine for Ebola, Marburg, and Lassa Viruses Contracts + Grants October 10, 2017 …
